ICAROHemoadsorption Cartridges for Antibiotics Removal in ICU Patients
This study aims to observe how effective hemoadsorption cartridges are in removing antibiotics from the body of patients in the intensive care unit by measuring changes in drug concentration.
Data Collection
Collected from today forward - ProspectiveInfections+5
+ Inflammation
+ Pathologic Processes
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: January 15, 2025
Actual date on which the first participant was enrolled.This study focuses on understanding how certain antibiotics behave in the body when patients in an Intensive Care Unit (ICU) are treated for severe infections like septic shock. The study specifically looks at the combination of antibiotics such as meropenem with either linezolid or daptomycin. These patients are also receiving a treatment called Continuous Renal Replacement Therapy (CRRT), which helps filter waste from the blood when the kidneys are not working well. The study aims to see how a device called the HA380 cartridge affects the levels of these antibiotics in the blood. This is important because understanding how these treatments interact could help improve the effectiveness and safety of treating severe infections in ICU patients. During the study, participants will undergo CRRT using a special machine that includes the HA380 cartridge to filter out inflammatory substances from their blood. Blood samples will be taken at different times to measure how much of the drug is present before and after it passes through the HA380 filter. The samples are carefully processed and stored to ensure accurate measurement using advanced techniques. This study is observational, meaning it looks at what happens naturally without intervening. The researchers will analyze the percentage change in drug concentration to understand the cartridge's impact. This can help determine whether the HA380 cartridge affects the effectiveness of the antibiotics, providing valuable insights into optimizing care for critically ill patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * stage 3 KDIGO consensus criteria, indication to CRRT * use of at least one of the following antibiotics meropenem, linezolid and daptomycin * \< 18 yo Exclusion Criteria: * \< 18 yo
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location